Effect of Positive End-Expiratory Pressure Titration on Venous Excess Ultrasound Score and Renal Outcomes in Patients With Acute Respiratory Distress Syndrome
1 other identifier
observational
40
0 countries
N/A
Brief Summary
This study is a prospective observational cohort study conducted planned to include 40 patients with ARDS to assess the effect of different levels of PEEP titration on VExUS score and renal outcomes in patients with Acute Respiratory Distress Syndrome.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Apr 2026
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 12, 2026
CompletedFirst Submitted
Initial submission to the registry
April 16, 2026
CompletedFirst Posted
Study publicly available on registry
April 22, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 20, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
October 12, 2026
April 22, 2026
April 1, 2026
5 months
April 16, 2026
April 16, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
VExUS score
Change in VExUS score in relation to different PEEP levels in mechanically ventilated patients with ARDS.
3 days
Development of acute kidney injury (AKI)
Development of acute kidney injury (AKI), defined and staged according to the KDIGO criteria: increase in serum creatinine by ≥0.3 mg/dL within 48 hours, or ≥1.5 times baseline within 7 days, or urine output \<0.5 mL/kg/hour for 6 hours.
3 days
Secondary Outcomes (3)
Requirement for renal replacement therapy (RRT) during ICU stay.
3 days
Length of ICU stay
4 to 7 days
ICU mortality
4 to 7 days
Interventions
The Venous Excess Ultrasound Score (VExUS) was calculated for each patient based on the assessment of systemic venous congestion using the following parameters: Inferior vena cava (IVC) diameter and respiratory collapsibility, Hepatic vein Doppler waveform, Portal vein Doppler pulsatility and Intrarenal venous Doppler pattern.
Eligibility Criteria
patients with ARDS within 24 hours of onset and mechanically ventilated for more than 24 hours.
You may qualify if:
- Age ≥18 years.
- Diagnosis of ARDS according to the Berlin criteria.
- Invasive mechanical ventilation ≥24 hours.
- Requirement of PEEP ≥5 cmH₂O.
You may not qualify if:
- Known end-stage renal disease on chronic dialysis.
- History of renal transplantation.
- Pregnancy.
- Known severe tricuspid regurgitation.
- Chronic liver disease with portal hypertension.
- Poor ultrasound window precluding adequate venous Doppler assessment.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 3 Days
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Lecturer of Critical Care Medicine
Study Record Dates
First Submitted
April 16, 2026
First Posted
April 22, 2026
Study Start
April 12, 2026
Primary Completion (Estimated)
September 20, 2026
Study Completion (Estimated)
October 12, 2026
Last Updated
April 22, 2026
Record last verified: 2026-04